These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

657 related articles for article (PubMed ID: 36129048)

  • 1. An update on the molecular biology of glioblastoma, with clinical implications and progress in its treatment.
    Verdugo E; Puerto I; Medina MÁ
    Cancer Commun (Lond); 2022 Nov; 42(11):1083-1111. PubMed ID: 36129048
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crosstalk between PI3K/AKT/mTOR and WNT/β-Catenin signaling in GBM - Could combination therapy checkmate the collusion?
    Daisy Precilla S; Biswas I; Kuduvalli SS; Anitha TS
    Cell Signal; 2022 Jul; 95():110350. PubMed ID: 35525406
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent advances in the use of PI3K inhibitors for glioblastoma multiforme: current preclinical and clinical development.
    Zhao HF; Wang J; Shao W; Wu CP; Chen ZP; To ST; Li WP
    Mol Cancer; 2017 Jun; 16(1):100. PubMed ID: 28592260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Wnt/beta-catenin and PI3K/Akt/mTOR Signaling Pathways in Glioblastoma: Two Main Targets for Drug Design: A Review.
    Shahcheraghi SH; Tchokonte-Nana V; Lotfi M; Lotfi M; Ghorbani A; Sadeghnia HR
    Curr Pharm Des; 2020; 26(15):1729-1741. PubMed ID: 32003685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epithelial membrane protein 1 promotes glioblastoma progression through the PI3K/AKT/mTOR signaling pathway.
    Miao L; Jiang Z; Wang J; Yang N; Qi Q; Zhou W; Feng Z; Li W; Zhang Q; Huang B; Chen A; Zhang D; Zhao P; Li X
    Oncol Rep; 2019 Aug; 42(2):605-614. PubMed ID: 31233190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progress in targeting PTEN/PI3K/Akt axis in glioblastoma therapy: Revisiting molecular interactions.
    Hashemi M; Etemad S; Rezaei S; Ziaolhagh S; Rajabi R; Rahmanian P; Abdi S; Koohpar ZK; Rafiei R; Raei B; Ahmadi F; Salimimoghadam S; Aref AR; Zandieh MA; Entezari M; Taheriazam A; Hushmandi K
    Biomed Pharmacother; 2023 Feb; 158():114204. PubMed ID: 36916430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Voxtalisib and low intensity pulsed ultrasound combinatorial effect on glioblastoma multiforme cancer stem cells via PI3K/AKT/mTOR.
    Tutak I; Ozdil B; Uysal A
    Pathol Res Pract; 2022 Nov; 239():154145. PubMed ID: 36240647
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting the PI3K/AKT/mTOR signaling pathway in glioblastoma: novel therapeutic agents and advances in understanding.
    Sami A; Karsy M
    Tumour Biol; 2013 Aug; 34(4):1991-2002. PubMed ID: 23625692
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Signaling pathways and therapeutic approaches in glioblastoma multiforme (Review).
    Khabibov M; Garifullin A; Boumber Y; Khaddour K; Fernandez M; Khamitov F; Khalikova L; Kuznetsova N; Kit O; Kharin L
    Int J Oncol; 2022 Jun; 60(6):. PubMed ID: 35445737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PTP4A3 is a target for inhibition of cell proliferatin, migration and invasion through Akt/mTOR signaling pathway in glioblastoma under the regulation of miR-137.
    Wang L; Liu J; Zhong Z; Gong X; Liu W; Shi L; Li X
    Brain Res; 2016 Sep; 1646():441-450. PubMed ID: 27328425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Wild‑type IDH1 affects cell migration by modulating the PI3K/AKT/mTOR pathway in primary glioblastoma cells.
    Shen X; Wu S; Zhang J; Li M; Xu F; Wang A; Lei Y; Zhu G
    Mol Med Rep; 2020 Sep; 22(3):1949-1957. PubMed ID: 32705169
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NQO1 drives glioblastoma cell aggressiveness through EMT induction via the PI3K/Akt/mTOR/Snail pathway.
    Zheng L; Yang S; Xu R; Yang Y; Quan J; Lin Z; Quan C
    Int J Oncol; 2023 Oct; 63(4):. PubMed ID: 37594082
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Wnt and PI3K/Akt/mTOR Survival Pathways as Therapeutic Targets in Glioblastoma.
    Barzegar Behrooz A; Talaie Z; Jusheghani F; Łos MJ; Klonisch T; Ghavami S
    Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. AKT pathway genes define 5 prognostic subgroups in glioblastoma.
    Joy A; Ramesh A; Smirnov I; Reiser M; Misra A; Shapiro WR; Mills GB; Kim S; Feuerstein BG
    PLoS One; 2014; 9(7):e100827. PubMed ID: 24984002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer Metabolism: The Role of Immune Cells Epigenetic Alteration in Tumorigenesis, Progression, and Metastasis of Glioma.
    Kanwore K; Kanwore K; Adzika GK; Abiola AA; Guo X; Kambey PA; Xia Y; Gao D
    Front Immunol; 2022; 13():831636. PubMed ID: 35392088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypoxia enhances the migration and invasion of human glioblastoma U87 cells through PI3K/Akt/mTOR/HIF-1α pathway.
    Huang W; Ding X; Ye H; Wang J; Shao J; Huang T
    Neuroreport; 2018 Dec; 29(18):1578-1585. PubMed ID: 30371540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR-548x and miR-4698 controlled cell proliferation by affecting the PI3K/AKT signaling pathway in Glioblastoma cell lines.
    Kalhori MR; Arefian E; Fallah Atanaki F; Kavousi K; Soleimani M
    Sci Rep; 2020 Jan; 10(1):1558. PubMed ID: 32005873
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIF1α/HIF2α-Sox2/Klf4 promotes the malignant progression of glioblastoma via the EGFR-PI3K/AKT signalling pathway with positive feedback under hypoxia.
    Wang P; Zhao L; Gong S; Xiong S; Wang J; Zou D; Pan J; Deng Y; Yan Q; Wu N; Liao B
    Cell Death Dis; 2021 Mar; 12(4):312. PubMed ID: 33762574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. mTOR-Dependent Cell Proliferation in the Brain.
    Ryskalin L; Lazzeri G; Flaibani M; Biagioni F; Gambardella S; Frati A; Fornai F
    Biomed Res Int; 2017; 2017():7082696. PubMed ID: 29259984
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PI3K Pathway Inhibition with NVP-BEZ235 Hinders Glycolytic Metabolism in Glioblastoma Multiforme Cells.
    Udawant S; Litif C; Lopez A; Gunn B; Schuenzel E; Keniry M
    Cells; 2021 Nov; 10(11):. PubMed ID: 34831287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.